Profil

Peters Pierre

Département des sciences cliniques

See author's contact details
Main Referenced Co-authors
Gothot, André  (16)
Lecut, Christelle  (6)
Kaux, Jean-François  (5)
Crielaard, Jean-Michel  (4)
Le Goff, Caroline  (4)
Main Referenced Keywords
Humans (5); PRP (3); Coagulation (2); COVID-19 (2); Hemorrhage (2);
Main Referenced Disciplines
Hematology (16)
Laboratory medicine & medical technology (5)
Orthopedics, rehabilitation & sports medicine (5)
Anesthesia & intensive care (4)
Cardiovascular & respiratory systems (3)

Publications (total 31)

The most downloaded
1592 downloads
Kaux, J.-F., Le Goff, C., Seidel, L., Peters, P., Gothot, A., Albert, A., & Crielaard, J.-M. (October 2009). Comparaison de 5 techniques de prération du PRP (Platelet-Rich Plasma ou plasma) [Paper presentation]. 24ème Congrès de Médecine Physique et Réadaptation, Lyon, France. https://hdl.handle.net/2268/16345

The most cited

70 citations (Scopus®)

Kaux, J.-F., Le Goff, C., Seidel, L., Peters, P., Gothot, A., Albert, A., & Crielaard, J.-M. (June 2011). Etude comparative de cinq techniques de préparation plaquettaire (Platelet-Rich Plasma). Pathologie Biologie, 59, 157-160. doi:10.1016/j.patbio.2009.04.007 https://hdl.handle.net/2268/13344

Vanassche, T., Orlando, C., VANDENBOSCH, K., Gadisseur, A., Hermans, C., Jochmans, K., Minon, J.-M., Motte, S., Peperstraete, H., Peters, P., SPRYNGER, M., Lancellotti, P., Dehaene, I., Emonts, P., Vandenbriele, C., Verhamme, P., & Oury, C. (2022). Belgian clinical guidance on anticoagulation management in hospitalised and ambulatory patients with COVID-19. Acta Clinica Belgica, 1-6. doi:10.1080/17843286.2020.1829252
Peer Reviewed verified by ORBi

LONGTON, J., Minon, J., PETERS, P., SEGHAYE, M.-C., & DRESSE, M.-F. (November 2021). Comment j’explore. Une anomalie du bilan d’hémostase en pédiatrie. Revue Médicale de Liège, 76 (11), 829-836.
Peer reviewed

Pelzer, D., LAURENT, C., PETERS, P., & Kaux, J.-F. (October 2020). Arthropathie hémophilique de la cheville : description de deux cas et revue de la littérature. Revue Médicale de Liège, 75 (10), 665-669.
Peer reviewed

DE VOEGHT, A., CALMES, D., BECK, F., SYLVESTRE, J.-B., DELVENNE, P., PETERS, P., VERTENOEIL, G., BARON, F., LAYIOS, N., & CANIVET, J.-L. (2020). Thrombotic microvascular injury is not mediated by thrombotic microangiopathy despite systemic complement activation in Covid-19 patients. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/256301.

Peters, P., SPRYNGER, M., Lancellotti, P., & Oury, C. (2020). Coagulopathies, risque thrombotique et anticoagulation dans la COVID-19. Revue Médicale de Liège, 75 (S1), 86-93.
Peer reviewed

Peters, P., & Gothot, A. (2020). Hémophilie : une maladie en marche. Revue Médicale de Liège, 75 (5-6), 322-328.
Peer reviewed

Harkati, R., Peters, P., Gothot, A., Staquet, B., & André, M. (2019). Comment j’explore… Les thrombopénies et thrombopathies constitutionnelles. Revue Médicale de Liège, 74 (11), 616-619.
Peer reviewed

HARKATI, R., Peters, P., Gothot, A., Staquet, B., & André, M. (2019). Diagnostic différentiel des thrombopénies et thrombopathies constitutionnelles : présentations cliniques et algorithmes décisionnels. Revue Médicale de Liège, 74 (12), 655-661.
Peer reviewed

Pillois, X., PETERS, P., Segers, K., & Nurden, A. T. (2018). In silico analysis of structural modifications in and around the integrin alphaIIb genu caused by ITGA2B variants in human platelets with emphasis on Glanzmann thrombasthenia. Molecular Genetics and Genomic Medicine, 1-12. doi:10.1002/mgg3.365
Peer Reviewed verified by ORBi

DUBOIS, N., PETERS, P., DENOOZ, R., & Charlier, C. (October 2017). Intérêt du suivi thérapeutique pharmacologique des anticoagulants oraux directs (DOACs) dans la pratique hospitalière [Poster presentation]. 6èmes Journées Internationales de Toxicologie, Liège, Belgium.

PETERS, P., LECUT, C., BOSSU, O., & GOTHOT, A. (25 November 2016). Performance evaluation of the new point-of-care coagulation analyzer Xprecia stride for measuring INR in VKA-treated patients – comparison with local laboratory automated reference method [Poster presentation]. 24ème congrès annuel de la Société belge de Thrombose Hémostase, Mechelen, Belgium.

LECUT, C., PETERS, P., FIORE, M., Delierneux, C., JOIRET, M., Hego, A., Oury, C., & GOTHOT, A. (20 November 2015). Phenotypic characterization of a patient with Glanzmann Thrombasthenia caused by a novel homozygous mutation in the ITGA2B gene [Poster presentation]. 23ème congrès annuel de la Société Belge de Thrombose-Hémostase, Mechelen, Belgium.

LECUT, C., PETERS, P., MASSION, P., & GOTHOT, A. (April 2015). Quelle place pour le test de génération de thrombine au sein du laboratoire de biologie clinique? Annales de Biologie Clinique, 73 (2), 137-149. doi:10.1684/abc.2014.1018
Peer Reviewed verified by ORBi

GOTHOT, A., GOSSET, C., LECUT, C., PETERS, P., & MASSION, P. (30 January 2015). Point-of-care devices assessing platelet function and clotting in sepsis: effect of thrombocytopenia and analytical variables [Poster presentation]. 30th General Annual Meeting of the Belgian Hematological Society.

LECUT, C., CLOTUCHE, C., LAGNY, M.-G., PETERS, P., Defraigne, J.-O., GOTHOT, A., & LARBUISSON, R. (30 January 2015). Hepcon(R) HMS and Hemochron(R) allow for similar anticoagulation management during cardiopulmonary bypass in low-risk patients undergoing cardiac surgery [Poster presentation]. 30th General Annual Meeting of the Belgian Hematological Society.

Flebus, L., Lombart, F., Sevrin, C., Defraigne, J.-O., Peters, P., Parhamifar, L., Molin, D. G. M., & Grandfils, C. (15 January 2015). Low molecular weight poly (2-dimethylamino ethylmethacrylate) polymers with controlled positioned fluorescent labeling: Synthesis, characterization and in vitro interaction with human endothelial cells. International Journal of Pharmaceutics, 478 (1), 278-287. doi:10.1016/j.ijpharm.2014.11.016
Peer Reviewed verified by ORBi

DELANAYE, P., DUBOIS, B., LUKAS, P., PETERS, P., KRZESINSKI, J.-M., Pottel, H., & CAVALIER, E. (2015). impact of stopping vitamin K antagonist therapy on concentrations of dephospho-uncarboxylated Matrix Gla protein [letter to the editor]. Clinical Chemistry and Laboratory Medicine, 53 (8), 191-193. doi:10.1515/cclm-2015-0073
Peer Reviewed verified by ORBi

HANS, G., Hartstein, G., ROEDIGER, L., Hubert, B., PETERS, P., & Senard, M. (2015). Impact of 6 % hydroxyethyl starch (HES) 130/0.4 on the correlation between standard laboratory tests and thromboelastography (TEG(R)) after cardiopulmonary bypass. Thrombosis Research, 135 (5), 984-9. doi:10.1016/j.thromres.2015.02.006
Peer Reviewed verified by ORBi

STEBELSKI, L., BRICHANT, J.-F., PIERARD, L., PETERS, P., & SENARD, M. (December 2014). Gestion péri-opératoire des nouveaux anticoagulants oraux : peu de données mais plusieurs approches ! Revue Médicale de Liège, 69 (12), 671-679.
Peer reviewed

LECUT, C., PETERS, P., & GOTHOT, A. (02 October 2014). Quelle place pour le test de génération de thrombine au sein du laboratoire de biologie clinique? [Paper presentation]. 2ème congrès de biologie clinique, Reims, France.

DELANAYE, P., DUBOIS, B., LUKAS, P., PETERS, P., KRZESINSKI, J.-M., & CAVALIER, E. (2014). Impact of the stopping of vitamin K antagonist treatment on concentrations of Dephosphorylated and uncarboxylated Matrix Gla protein [Poster presentation]. ASN Kidney Week, Philadelphia, United States - Pennsylvania.

LEDOUBLE, V., BECK, E., PETERS, P., LAMPROYE, A., & Louis, E. (2013). Thrombose portale étendue chez un patient sous anti-vitamine K. Revue Médicale de Liège, (68(7-8)), 382-6.
Peer reviewed

MASSION, P., PETERS, P., LEDOUX, D., ZIMERMANN, V., CANIVET, J.-L., Massion, P. P., Damas, P., & GOTHOT, A. (2012). Persistent hypocoagulability in patients with septic shock predicts greater hospital mortality: impact of impaired thrombin generation. Intensive Care Medicine, 38 (8), 1326-35. doi:10.1007/s00134-012-2620-2
Peer Reviewed verified by ORBi

PETERS, P., DEFRAIGNE, J., & GOTHOT, A. (2012). Anticoagulants oraux : nouveaux horizons. Revue Médicale de Liège, 67, 37-44.
Peer reviewed

Kaux, J.-F., Le Goff, C., Renouf, J., Lutteri, L., Peters, P., Gothot, A., & Crielaard, J.-M. (October 2011). Comparison of the platelet concentrations obtained in platelet-rich plasma (PRP) between the GPS™ II and GPS™ III systems. Pathologie Biologie, 59 (5), 275-277. doi:10.1016/j.patbio.2010.11.002
Peer Reviewed verified by ORBi

Kaux, J.-F., Le Goff, C., Seidel, L., Peters, P., Gothot, A., Albert, A., & Crielaard, J.-M. (June 2011). Etude comparative de cinq techniques de préparation plaquettaire (Platelet-Rich Plasma). Pathologie Biologie, 59, 157-160. doi:10.1016/j.patbio.2009.04.007
Peer Reviewed verified by ORBi

WERTZ, D., Boveroux, P., PETERS, P., LENELLE, J., & FRANSSEN, C. (2011). Surgical resection of a sphenoid wing meningioma in a patient with Glanzmann thrombasthenia. Acta Anaesthesiologica Belgica, 62 (2), 83-6.
Peer Reviewed verified by ORBi

Clanet, M., CHANTRAINE, F., DEWANDRE, P.-Y., PETERS, P., Foidart, J.-M., & Brichant, J.-F. (2011). Analgésie épidurale obstétricale et pseudoxanthome élastique : à propos d’un cas. Annales Françaises d'Anesthésie et de Réanimation, 30 (9), 685-7. doi:10.1016/j.annfar.2011.05.008
Peer Reviewed verified by ORBi

Kaux, J.-F., Le Goff, C., Renouf, J., Peters, P., Lutteri, L., Gothot, A., & Crielaard, J.-M. (20 March 2010). GPS™ II and GPS™ III: comparison of obtained platelets concentrations [Poster presentation]. VVS Biennial Congress for Sports Medicine and Sports Sciences, Brugge, Belgium.

Kaux, J.-F., Le Goff, C., Seidel, L., Peters, P., Gothot, A., Albert, A., & Crielaard, J.-M. (October 2009). Comparaison de 5 techniques de prération du PRP (Platelet-Rich Plasma ou plasma) [Paper presentation]. 24ème Congrès de Médecine Physique et Réadaptation, Lyon, France.

Peters, P., & Gothot, A. (2009). La Thrombinographie : vers une globalisation des tests de la coagulation. Revue Médicale de Liège, 64 (4), 199-203.
Peer reviewed

Contact ORBi